Scarica l'app Stockscreener
4.59
1.08%
-0.05
Dopo l'orario di chiusura:
3.43
-1.16
-25.27%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Mimedx Group Inc Borsa (MDXG) Ultime notizie
What's Driving the Buzz Around MiMedx Group, Inc. (MDXG) in Healthcare Stocks? - Kalkine Media
What Does the AXIOFILL Court Ruling Mean for MiMedx (NASDAQ:MDXG)? - Kalkine Media
MiMedx Group: Court Remands Both Matters to FDA for Further Consideration Consistent With Order >MDXG - Moomoo
MIMEDX Announces Favorable Federal Court Ruling in AXIOFILL® Regulatory Classification Matter - Investing News Network
Court vacates FDA rulings on MiMedx’s AXIOFILL classification - Investing.com
U.S. District Court Orders FDA to Reclassify MiMedx Wound Powder as Device - Lawxy AI
FDA Must Revisit MiMedx Wound Care Powder Classification - Law360
MiMedx Group, Inc (MDXG) Stock Analysis: Exploring a 53.85% Potential Upside in Biotechnology - DirectorsTalk Interviews
MiMedx Group stock steadies as investors look to upcoming catalysts - AD HOC NEWS
MiMedx Group (MDXG) Holds Steady at $4.76 as Traders Eye $5.00 ResistanceMerger Arbitrage - careplusvn.com
Cantor Fitzgerald reiterates Overweight on MiMedx stock at $8 By Investing.com - Investing.com India
Two New York conferences will include MIMEDX executives on Sept. 9 and 10 - Stock Titan
MIMEDX GROUP, INC. SEC Filing (Sep 8, 2026) - Stock Titan
Sanara MedTech Seeks Shareholder Approval for Merger With MiMedx - The Globe and Mail
MDXG Should I Buy - Intellectia AI
MiMedx (MDXG) Earnings Snapshot: Profit Per Share Falls Below Its Benchmark in the Reported Period; Session Move - dars.gov.et
MiMedx Group (NASDAQ: MDXG) readies shares for business combination - Stock Titan
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of MiMedx Group, Inc.MDXG - Eastern Progress
Sanara MedTech (SMTI) agrees to MiMedx takeover, targeting year-end close - Stock Titan
MiMedx (MDXG) Earnings Metrics: The Bottom-Line Figure Trails Its Comparison at the Close; Immediate Response: Shares Move 3.58% Up on the DayEnergy Earnings Report - vinanet.vn
MDXG Q2 2026 Earnings: Wider-than-Expected Loss as EPS Misses Estimates by 106%Post-Announcement Reaction - vinanet.vn
Tranche Update on MiMedx Group, Inc.'s Equity Buyback Plan announced on February 25, 2026. - marketscreener.com
MiMedx Group (SMTI partner) clarifies Sanara merger fees and $33 cash-plus-stock deal - Stock Titan
Sanara MedTech Corrects Termination Fees in Merger Deal with MiMedx - Kalkine Media
Sanara MedTech (SMTI) sets $33 cash plus MiMedx stock merger terms and corrects fees - Stock Titan
Sanara MedTech (SMTI) sets $33 cash plus MiMedx stock per share in merger - Stock Titan
MiMedx Group, Inc (MDXG) Stock Report: Exploring a 63.93% Potential Upside in the Biotech Arena - DirectorsTalk Interviews
MiMedx Group Inc (MDXG) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
MiMedx Group, Inc Revenue Breakdown – NASDAQ:MDXG - TradingView
MiMedx Group (MDXG) Climbs 3.83% to $4.34, Approaching Key Resistance LevelPrice Action Signals - dars.gov.et
MiMedx (MDXG) Q2 2026 Earnings Call Transcript - AOL.com
MiMedx Group Inc (MDXG) Stock News Today - TradingKey
MiMedx Group's (NASDAQ:MDXG) Soft Earnings Are Actually Better Than They Appear - simplywall.st
Lazard Asset Management LLC Sells 264,718 Shares of MiMedx Group, Inc $MDXG - MarketBeat
MiMedx Group (MDXG) Holds Steady Near $4.24 as Consolidation ContinuesUnusual Put Volume - dars.gov.et
MiMedx Group (NASDAQ:MDXG) Stock Price Up 7.8%What's Next? - MarketBeat
Renaissance Technologies LLC Has $11.93 Million Stake in MiMedx Group, Inc $MDXG - MarketBeat
Wall Street Zen Downgrades MiMedx Group (NASDAQ:MDXG) to Sell - MarketBeat
Mimedx to buy Sanara for $350M to move beyond wound care - bioworld.com
MiMedx to Buy Sanara MedTech for $350M - Medical Product Outsourcing
MiMedx to acquire Sanara MedTech for $350M - MassDevice
MiMedx Group affirms FY26 sales guidance of $260-290M - scanx.trade
MiMedx Group Number of Employees 2026 | Employee Count & Headcount Data - Revelio Labs
MiMedx Group Q2 Earnings Call Highlights - tradingview.com
MiMedx Group Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Is MiMedx Group Inc (MDXG) Undervalued After Q2 Earnings Beat? E - GuruFocus
MiMedx: Q2 Earnings Snapshot - Marietta Daily Journal
MIMEDX to Acquire Sanara MedTech - The Manila Times
MIMEDX Announces Second Quarter 2026 Operating & Financial Results - GlobeNewswire
MiMedx agrees to buy Sanara MedTech for $35 a share (SMTI:NASDAQ) - Seeking Alpha
Earnings To Watch: MiMedx Group Inc (MDXG) Q2 2026 -- GF Value Sees 35% Upside - GuruFocus
MiMedx Group Inc (MDXG) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
MiMedx Group Inc (MDXG) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
MiMedx Group Inc (MDXG) Earnings Date & Reports & Earnings News - TradingKey
MiMedx Group Inc (MDXG) Institutional Confidence - TradingKey
MiMedx Group Inc (MDXG) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
MiMedx Group Inc expected to post a loss of 5 cents a shareEarnings Preview - TradingView
MiMedx Group Inc (MDXG) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
MiMedx Group Inc (MDXG) Valuation: PE, PB & Fair Value Analysis - TradingKey
TradingKey - TradingKey
MDXG|MiMedx Group Inc|Price:4.340|Chg%:+0.080 - TradingKey
Paradigm Capital Management Inc. NY Boosts Stock Position in MiMedx Group, Inc $MDXG - MarketBeat
MiMedx Group, Inc Revenue Breakdown – BOATS:MDXG - TradingView
MDXG|MiMedx Group Inc|Price:4.200|Chg%:+0.070 - TradingKey
MiMedx Group (MDXG) Holds Near Support Amid Modest PullbackEntry Point Alerts - dars.gov.et
MiMedx Group (MDXG) Expected to Announce Earnings on Wednesday - MarketBeat
0.05%
0.82%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):